Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - OTHER CURRENT ASSETS
Other Current Assets FATE - Fate Therapeutics, Inc.
14.5 M
LAST VALUE
28.35%
2 YEAR CAGR
31.56%
5 YEAR CAGR
28.02%
10 YEAR CAGR